Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01357369 · ClinicalTrials.gov registry record
Study of Drug Concentration of Ondansetron and Cefazolin in Mothers and Neonates
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 20
- Enrollment target
NCT01357369: Completed study, sponsored by Stanford University.
NCT01357369 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01357369 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This study proposes to look at the pharmacokinetics of two drugs (Cefazolin and ondansetron) given routinely to pregnant women who are planning to deliver via cesarean section. The investigators will evaluate the metabolism of both drugs by the pregnant woman, the placental transfer over time, and the subsequent metabolism of the transferred drug in the neonate.
Interventions
- PROCEDURE Phlebotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01357369
The ClinicalTrials.gov registry entry for NCT01357369 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Phlebotomy is the first listed.
NCT01357369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01357369 about?
NCT01357369 is a clinical study titled "Study of Drug Concentration of Ondansetron and Cefazolin in Mothers and Neonates". This study proposes to look at the pharmacokinetics of two drugs (Cefazolin and ondansetron) given routinely to pregnant women who are planning to deliver via cesarean section. The investigators will evaluate the metabolism of both drugs by the pregnant woman, the placental transfer over time, and t...
What is the current status of trial NCT01357369?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2011-01. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01357369?
The interventions under investigation include: Phlebotomy (PROCEDURE).
Who is sponsoring clinical trial NCT01357369?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.